Standardized viability test required for preventive, immunomodulator and recombinant BCG vaccine.
The protective and immunostimulating effect of the living attenuated BCG vaccine cannot be expressed by bacterial mass (mg/dose). Colony forming units (CFU 10(6)/ml) and 95% confidence limit estimates as precise in vitro potency tests are required for the exact evaluation of the immunogenicity and reactogenicity of the BCG vaccine. The laboratory technique and computerized statistical analysis presented here ensure the precision and validity of the BCG viability test, permit the standardized BCG CFU 10(6)/ml unbiased point and confidence interval estimation for preventive and immunomodulator administration of the BCG vaccines and the evaluation of the genetic transformation frequency in recombinant BCG experiments.
Lugosi
L
L
rDNA-BCG Laboratory, Institut Pasteur de Lille, France.
D001500:BCG Vaccine / Q000592:standards*; D001431:Bacteriological Techniques; D005612:Freeze Drying; D009163:Mycobacterium bovis / Q000254:growth & development; D011786:Quality Control; D014613:Vaccines, Attenuated / Q000592:standards; D014614:Vaccines, Synthetic; D014944:World Health Organization
D001500:BCG Vaccine; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic